Kavar Capital Partners Group’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,575
Closed -$197K 148
2022
Q3
$197K Sell
16,575
-17,375
-51% -$263K 0.05% 135
2022
Q2
$518K Sell
33,950
-2,400
-7% -$43.2K 0.12% 105
2022
Q1
$768K Sell
36,350
-200
-0.5% -$4.31K 0.17% 92
2021
Q4
$864K Buy
36,550
+3,000
+9% +$64.3K 0.18% 93
2021
Q3
$673K Sell
33,550
-500
-1% -$10.2K 0.15% 104
2021
Q2
$684K Buy
+34,050
New +$728K 0.17% 100
2019
Q3
Sell
-375
Closed -$7K 334
2019
Q2
$7K Buy
+375
New +$6.75K ﹤0.01% 399

Other funds holding MPT

Kavar Capital Partners Group's MPT Position: Q4 2022 in Review

Kavar Capital Partners Group sold out of Medical Properties Trust (MPT) in Q4 2022, closing a stake of 16,575 shares — an estimated $197K sold.

Kavar Capital Partners Group first reported a position in MPT in Q2 2019 and held it in 7 quarters. The position peaked at $864K in Q4 2021. 639 funds tracked by Wall St. Rank hold MPT as of Q4 2022.

  • Kavar Capital Partners Group reported no remaining Medical Properties Trust position as of Q4 2022 after selling out during the quarter.
  • Kavar Capital Partners Group sold 16,575 Medical Properties Trust shares in Q4 2022, an estimated $197K.
  • Kavar Capital Partners Group first reported a position in Medical Properties Trust in Q2 2019 and held it in 7 quarters.
  • Kavar Capital Partners Group's Medical Properties Trust position peaked at $864K in Q4 2021.
  • 639 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2022.

Based on Kavar Capital Partners Group's 13F filing for Q4 2022, filed 10 Feb 2023.